{"title":"Prevalence of Entamoeba gingivalis and Trichomonas tenax among Patients suffering from Chronic Systemic Diseases in Egypt ","authors":"Eman M H Méabed, R. Henin","doi":"10.21608/aeji.2022.171351.1264","DOIUrl":null,"url":null,"abstract":"in sera drawn from cases and controls. Results: The prevalence of oral protozoa was significantly increased in chronic diseases, as E. gingivalis was reported in 80%, 76, and 74% of diabetic, renal, and hepatic groups of patients respectively compared to 20% in the control healthy group. While T. tenax was reported in 70%, 62%, and 64% respectively compared to 16 % in the control group. Conclusion: This high prevalence in chronic systemic disease needs more investigations concerning its pathogenesis, immunological mediators that may affect systemic diseases and the interplay between them .","PeriodicalId":261891,"journal":{"name":"Afro-Egyptian Journal of Infectious and Endemic Diseases","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Afro-Egyptian Journal of Infectious and Endemic Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/aeji.2022.171351.1264","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
in sera drawn from cases and controls. Results: The prevalence of oral protozoa was significantly increased in chronic diseases, as E. gingivalis was reported in 80%, 76, and 74% of diabetic, renal, and hepatic groups of patients respectively compared to 20% in the control healthy group. While T. tenax was reported in 70%, 62%, and 64% respectively compared to 16 % in the control group. Conclusion: This high prevalence in chronic systemic disease needs more investigations concerning its pathogenesis, immunological mediators that may affect systemic diseases and the interplay between them .